Movement Alert｜Ali Health Falls 3.01% in Regular Trading, Post-Earnings Pressure and Prescription Drug Online Retail Regulations Continue to Weigh

Market Focus06-04 11:14

On June 4, Ali Health fell 3.01% in regular trading, trading at HK$3.55/share, with trading volume of HK$189 million, extending its post-earnings weakness.

On the news front, the company's previously reported FY26 results showed second-half revenue growth of only 7.6%, significantly below the market consensus of 13.8%. Following the results, UBS, Goldman Sachs, CLSA, and Bank of America collectively cut target prices and earnings forecasts, with UBS maintaining a Sell rating and lowering its target to HK$3.6. Meanwhile, the newly issued prescription drug online retail compliance guidelines — banning AI-based prescription review and restricting prescription drug promotions — are expected to raise platform compliance costs and pressure near-term profitability for online pharmaceutical platforms.

Sector-wide weakness reinforced the decline, with JD Health down 2.15%, PA Good Doctor down 1.99%, and Meituan down 2.86%, reflecting broad selling pressure across the Internet and Direct Marketing Retail sector.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107246324?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 11:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107246324","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Ali Health Falls 3.01% in Regular Trading, Post-Earnings Pressure and Prescription Drug Online Retail Regulations Continue to Weigh","media":"Market Focus","content":"<p><p>On June 4, Ali Health fell 3.01% in regular trading, trading at HK$3.55/share, with trading volume of HK$189 million, extending its post-earnings weakness.</p><p>On the news front, the company's previously reported FY26 results showed second-half revenue growth of only 7.6%, significantly below the market consensus of 13.8%. Following the results, UBS, Goldman Sachs, CLSA, and Bank of America collectively cut target prices and earnings forecasts, with UBS maintaining a Sell rating and lowering its target to HK$3.6. Meanwhile, the newly issued prescription drug online retail compliance guidelines — banning AI-based prescription review and restricting prescription drug promotions — are expected to raise platform compliance costs and pressure near-term profitability for online pharmaceutical platforms.</p><p>Sector-wide weakness reinforced the decline, with JD Health down 2.15%, PA Good Doctor down 1.99%, and Meituan down 2.86%, reflecting broad selling pressure across the Internet and Direct Marketing Retail sector.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Ali Health Falls 3.01% in Regular Trading, Post-Earnings Pressure and Prescription Drug Online Retail Regulations Continue to Weigh</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Ali Health Falls 3.01% in Regular Trading, Post-Earnings Pressure and Prescription Drug Online Retail Regulations Continue to Weigh\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-04 11:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 4, Ali Health fell 3.01% in regular trading, trading at HK$3.55/share, with trading volume of HK$189 million, extending its post-earnings weakness.</p><p>On the news front, the company's previously reported FY26 results showed second-half revenue growth of only 7.6%, significantly below the market consensus of 13.8%. Following the results, UBS, Goldman Sachs, CLSA, and Bank of America collectively cut target prices and earnings forecasts, with UBS maintaining a Sell rating and lowering its target to HK$3.6. Meanwhile, the newly issued prescription drug online retail compliance guidelines — banning AI-based prescription review and restricting prescription drug promotions — are expected to raise platform compliance costs and pressure near-term profitability for online pharmaceutical platforms.</p><p>Sector-wide weakness reinforced the decline, with JD Health down 2.15%, PA Good Doctor down 1.99%, and Meituan down 2.86%, reflecting broad selling pressure across the Internet and Direct Marketing Retail sector.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00241","symbol_name":"阿里健康","start_time":0,"source_url":"","article_id":"1107246324","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107246324","pubTimestamp":1780542885,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 4, Ali Health fell 3.01% in regular trading, trading at HK$3.55/share, with trading volume of HK$189 million, extending its post-earnings weakness.On the news front, the company's previously...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00241":"阿里健康"},"translate_title":"动向提示|阿里健康常规交易跌3.01%财报后压力及处方药线上零售监管持续承压","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1},"content_text":"On June 4, Ali Health fell 3.01% in regular trading, trading at HK$3.55/share, with trading volume of HK$189 million, extending its post-earnings weakness.On the news front, the company's previously reported FY26 results showed second-half revenue growth of only 7.6%, significantly below the market consensus of 13.8%. Following the results, UBS, Goldman Sachs, CLSA, and Bank of America collectively cut target prices and earnings forecasts, with UBS maintaining a Sell rating and lowering its target to HK$3.6. Meanwhile, the newly issued prescription drug online retail compliance guidelines — banning AI-based prescription review and restricting prescription drug promotions — are expected to raise platform compliance costs and pressure near-term profitability for online pharmaceutical platforms.Sector-wide weakness reinforced the decline, with JD Health down 2.15%, PA Good Doctor down 1.99%, and Meituan down 2.86%, reflecting broad selling pressure across the Internet and Direct Marketing Retail sector.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107246324","isCrawlerRequest":true}